RhumbLine Advisers’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.14M | Sell |
49,216
-5,169
| -10% | -$224K | ﹤0.01% | 1848 |
|
|
2025
Q1 | $2.03M | Buy |
54,385
+1,665
| +3% | +$62.2K | ﹤0.01% | 1801 |
|
|
2024
Q4 | $2.39M | Buy |
52,720
+1,750
| +3% | +$79.3K | ﹤0.01% | 1789 |
|
|
2024
Q3 | $2.99M | Buy |
50,970
+1,535
| +3% | +$90.2K | ﹤0.01% | 1681 |
|
|
2024
Q2 | $1.95M | Sell |
49,435
-6,261
| -11% | -$246K | ﹤0.01% | 1900 |
|
|
2024
Q1 | $3.7M | Buy |
55,696
+28,468
| +105% | +$1.89M | ﹤0.01% | 1578 |
|
|
2023
Q4 | $761K | Buy |
27,228
+908
| +3% | +$25.4K | ﹤0.01% | 2419 |
|
|
2023
Q3 | $561K | Buy |
+26,320
| New | +$561K | ﹤0.01% | 2557 |
|